Hisamitsu Pharmaceutical
Launch date
Employees
Market cap
€2.0b
Enterprise valuation
€1.2b (Public information from Sep 2024)
Share price
JPY3971 4530.T
Tosu Saga Prefecture (HQ)
Financials
Estimates*
| JPY | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 114.5b | 120.2b | 128.3b | 141.7b | 157.0b | 166.0b | 172.5b |
| % growth | (19 %) | 5 % | 7 % | 10 % | 11 % | 6 % | 4 % |
| EBITDA | 16.2b | 17.0b | 21.0b | 24.9b | - | - | - |
| % EBITDA margin | 14 % | 14 % | 16 % | 18 % | - | - | - |
| Profit | 9.3b | 9.7b | 11.7b | 14.0b | 16.4b | 16.9b | 19.5b |
| % profit margin | 8 % | 8 % | 9 % | 10 % | 10 % | 10 % | 11 % |
| EV / revenue | 3.6x | 1.3x | 1.3x | 1.2x | 1.9x | 1.8x | 1.7x |
| EV / EBITDA | 25.3x | 9.3x | 8.1x | 6.8x | - | - | - |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| N/A | AUD300k | Angel | |
| N/A | JPY100m | Early VC | |
| N/A | AUD800k | Angel | |
| N/A | AUD1.5m | Seed | |
| Total Funding | €2.2m | ||
